SANTA MONICA, Calif., July 9 /PRNewswire-FirstCall/ -- Cord Blood
America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem
cell preservation company (http://www.cordblood-america.com) focused on
bringing the life saving potential of stem cells to families nationwide and
internationally, today said that Matthew Schissler, CEO, was interviewed
about the Company's achievements and future strategies by Francis Gaskins,
a financial analyst.
The complete interview is available at http://www.stoxrox.com/cbai-7-8-08-b.mp3 .
Mr. Schissler in the interview said the Company's a.bourkas Co. United subsidiary in Greece will expand into Germany in August. "Europe is ahead of the U.S. in umbilical cord blood storage, with up to 10 percent of the families in Greece participating, and we envision similar results in Germany," Cord Blood America's CEO said.
Mr. Schissler made the point that the recent financial vehicle, established for the Company and detailed in an 8-K filing, will allow the Company options in using non-toxic equity for growth, expansion and reduction of debt.
Specifically, Mr. Schissler stressed that CBAI will move forward with accelerated organic growth and an aggressive acquisition strategy over the next two years. "We are close to running cash flow positive," Mr. Schissler said. He also stressed an increased emphasis on the Company's successful practice of using insurance partners to expand its business to other parts of the country.
The stem cells from the umbilical cord are a perfect match for later transplant purposes and it is so important that families understand this is a one-in-a-lifetime opportunity for the child, Cord Blood America's CEO said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of
|SOURCE Cord Blood America, Inc.|
Copyright©2008 PR Newswire.
All rights reserved